Intraoral electrostimulator for xerostomia relief: a long-term, multicenter, open-label, uncontrolled, clinical trial

Objective A previous sham-controlled multinational study demonstrated the short-term efficacy and safety for xerostomia treatment of an intraoral device that delivers electrostimulation to the lingual nerve. The objective of this study was to test the hypothesis that those beneficial effects would b...

Descripción completa

Detalles Bibliográficos
Autores: Alajbeg, Iva, Falcào, Denise Pinheiro, tran, simon d, Martín-Granizo, Rafael A., Lafaurie, Gloria Ines, Matranga, Domenica, Pejda, Slavica, Vuletic, Lea, Mantilla, Rubén Darío, Leal, Soraya Coelho, Barreto Bezerra, Ana Cristina, Ménard, Henri André, Kimoto, Suguru, Pan, Shaoxia, Maniegas, Lourdes, Krushinski, Cheryl A., MELILLI, Dario, campisi, giuseppina, Paderni, Carlo, Bautista Mendoza, Gloria R., Yepes, Juan Fernando, Lindh, Liselott, Koray, Meltem Ozar, Mumcu, Gonca, Elad, Sharon, zeevi, itai, Aldape Barrios, Beatriz Catalina, López Sánchez, Rodrigo M., Lassauzay, Claire, Fromentin, Olivier, Beiski, Ben Z., Strietzel, Frank, Konttinen, Yrjó Tapio, Wolff, Andy, Zunt, Susan L.
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2012
País:Colombia
Institución:Universidad El Bosque
Repositorio:Repositorio U. El Bosque
Idioma:inglés
OAI Identifier:oai:repositorio.unbosque.edu.co:20.500.12495/3579
Acceso en línea:http://hdl.handle.net/20.500.12495/3579
https://doi.org/10.1016/j.oooo.2012.01.012
https://repositorio.unbosque.edu.co
Access Level:acceso abierto
Palabra clave:Xerostomía
Nervio lingual
Estimulación eléctrica transcutánea del nervio
Descripción
Sumario:Objective A previous sham-controlled multinational study demonstrated the short-term efficacy and safety for xerostomia treatment of an intraoral device that delivers electrostimulation to the lingual nerve. The objective of this study was to test the hypothesis that those beneficial effects would be sustained over an 11-month period. Study Design The device was tested on a mixed sample of 94 patients with xerostomia in an open-label, uncontrolled, prospective multicenter trial. Statutory outcome assessments were done at 5th, 8th, and 11th months and analyzed by multiple comparisons. Results Improvements achieved at month 5 from baseline were sustained throughout the follow-up period for the primary outcome, xerostomia severity, and the secondary outcomes resting whole salivary flow rate, xerostomia frequency, oral discomfort, and difficulties in speech, swallowing, and sleeping. No significant side effects were detected. Conclusions The beneficial effects of a removable intraoral electrostimulating device were sustained for an 11-month period.

Similares en LA Referencia